2019
DOI: 10.1002/2211-5463.12603
|View full text |Cite
|
Sign up to set email alerts
|

Annexin A1 peptide and endothelial cell‐conditioned medium modulate cervical tumorigenesis

Abstract: Cervical cancer is one of the leading causes of cancer death in women worldwide, and its tumorigenesis can be influenced by the microenvironment. The anti‐inflammatory protein annexin A1 (ANXA1) has been reported to be associated with cancer progression and metastasis, suggesting that it plays a role in regulating tumour cell proliferation. Here, we examined the effect of the N‐terminal peptide Ac2‐26 of ANXA1 on the HaCaT cell line (normal) and HeLa cell line (cervical cancer) co‐cultured with endothelium cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 60 publications
0
5
0
Order By: Relevance
“…In order to better understand the mechanisms of cancer progression, some mediators (PTGS2 and PTGER4), which have been extensively studied by our research group previously, have been verified [ 34 , 35 ]. In addition, tumorigenic cells have a characteristic of uncontrolled growth, and it is known that as arachidonic acid derivatives participate in inflammation and are also closely linked to tumor development, with PTGS2 being highly expressed in hyperplastic tissues, the study of the genes of this inflammatory pathway is necessary in head and neck cancer [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…In order to better understand the mechanisms of cancer progression, some mediators (PTGS2 and PTGER4), which have been extensively studied by our research group previously, have been verified [ 34 , 35 ]. In addition, tumorigenic cells have a characteristic of uncontrolled growth, and it is known that as arachidonic acid derivatives participate in inflammation and are also closely linked to tumor development, with PTGS2 being highly expressed in hyperplastic tissues, the study of the genes of this inflammatory pathway is necessary in head and neck cancer [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, ANXA1 N-terminal mimetic peptide Ac 2–26 has been proposed as a potential therapeutic strategy for cancer treatment, targeting ANXA1-mediated functions and related signaling pathways. As a proof of principle, it has been demonstrated that Ac 2–26 is able to decrease the proliferation of cervical cancer cells, through the activation of the MAPK family and targeting p53 to arrest the cell cycle ( Cardin et al, 2019 ). It has also been showed that Ac 2–26 could be used to treat non-small cell lung cancer (NSCLC), regulating NFkB pathway ( Guan et al, 2019 ).…”
Section: Annexin A1mentioning
confidence: 99%
“…The protective anti-inflammatory action of ANXA1 has since been demonstrated in several models, including arthritis, heterologous skin transplantation, cancer, eye allergy, heart failure, lung injury, nonalcoholic steatosis, myocardial infarction, and skeletal muscle injury [19][20][21][22][23][24][25][26][27][28][29][30].…”
Section: Anxa1 and Inflammatory Processesmentioning
confidence: 99%